• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Alterations in receptors for thyrotropin-releasing hormone, serotonin, and acetylcholine in amyotrophic lateral sclerosis.

作者信息

Manaker S, Caine S B, Winokur A

机构信息

Department of Medicine, University of Pennsylvania, Philadelphia 19104.

出版信息

Neurology. 1988 Sep;38(9):1464-74. doi: 10.1212/wnl.38.9.1464.

DOI:10.1212/wnl.38.9.1464
PMID:3412596
Abstract

We utilized quantitative autoradiography to examine thyrotropin-releasing hormone (TRH) receptors, serotonin type 1A (5-HT1A) receptors, muscarinic cholinergic receptors, choline uptake sites, beta-adrenergic receptors, and norepinephrine uptake sites in discrete laminae of spinal cord from patients with amyotrophic lateral sclerosis (ALS) and non-neurologic controls. We found decreases of over 50% in the concentration of TRH receptors in lamina IX of cervical, thoracic, and lumbar spinal cord from ALS patients. Similar reductions were noted in concentrations of muscarinic cholinergic receptors in lamina IX of spinal cords from ALS patients. Significant increases of up to 140% in 5-HT1A receptor densities were noted in lamina IX of spinal cords from ALS patients. No differences were noted between the concentrations of beta-adrenergic receptors or norepinephrine uptake sites in patients with ALS and controls. These findings suggest that TRH and 5-HT may be involved in the pathophysiology of ALS, and act in a comodulatory role in the normal spinal cord.

摘要

相似文献

1
Alterations in receptors for thyrotropin-releasing hormone, serotonin, and acetylcholine in amyotrophic lateral sclerosis.
Neurology. 1988 Sep;38(9):1464-74. doi: 10.1212/wnl.38.9.1464.
2
Autoradiographic localization of thyrotropin-releasing hormone receptors in amyotrophic lateral sclerosis spinal cord.
Neurology. 1985 Nov;35(11):1650-3. doi: 10.1212/wnl.35.11.1650.
3
Cholinergic, opioid and glycine receptor binding sites localized in human spinal cord by in vitro autoradiography. Changes in amyotrophic lateral sclerosis.
Acta Neurol Scand. 1985 Sep;72(3):299-306. doi: 10.1111/j.1600-0404.1985.tb00874.x.
4
Concentrations of immunoreactive thyrotropin-releasing hormone in spinal cord of patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者脊髓中免疫反应性促甲状腺激素释放激素的浓度。
Am J Med Sci. 1984 Mar-Apr;287(2):34-6. doi: 10.1097/00000441-198403000-00007.
5
Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors.肌萎缩侧索硬化症:神经递质受体的改变
Ann Neurol. 1983 Jul;14(1):8-16. doi: 10.1002/ana.410140103.
6
Amyotrophic lateral sclerosis: thyrotropin-releasing hormone and histidyl proline diketopiperazine in the spinal cord and cerebrospinal fluid.肌萎缩侧索硬化症:脊髓和脑脊液中的促甲状腺激素释放激素与组氨酰脯氨酸二酮哌嗪
Neurology. 1986 Sep;36(9):1218-23. doi: 10.1212/wnl.36.9.1218.
7
Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord.肌萎缩侧索硬化症:脊髓中去甲肾上腺素能和血清素能递质系统的变化。
Brain Res. 1991 Dec 6;566(1-2):54-60. doi: 10.1016/0006-8993(91)91680-y.
8
Growth factor receptors in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的生长因子受体
Mol Neurobiol. 1994 Aug-Dec;9(1-3):225-31. doi: 10.1007/BF02816121.
9
Amyotrophic lateral sclerosis: quantitative autoradiography of [3H]MK-801/NMDA binding sites in spinal cord.肌萎缩侧索硬化症:脊髓中[3H]MK-801/N-甲基-D-天冬氨酸受体结合位点的定量放射自显影术
Neurosci Lett. 1993 Sep 3;159(1-2):191-4. doi: 10.1016/0304-3940(93)90831-5.
10
Cholinergic markers in ALS spinal cord.肌萎缩侧索硬化症脊髓中的胆碱能标志物。
J Neurol Sci. 1992 Mar;108(1):114-7. doi: 10.1016/0022-510x(92)90196-r.

引用本文的文献

1
Deciphering hypothalamic pathology in ALS: insights into non-motor symptoms and disease progression.解读肌萎缩侧索硬化症中的下丘脑病理学:对非运动症状和疾病进展的见解。
EBioMedicine. 2025 Jul 11;118:105845. doi: 10.1016/j.ebiom.2025.105845.
2
The Serotonergic System and Amyotrophic Lateral Sclerosis: A Review of Current Evidence.血清素能系统与肌萎缩侧索硬化症:当前证据综述
Cell Mol Neurobiol. 2023 Aug;43(6):2387-2414. doi: 10.1007/s10571-023-01320-0. Epub 2023 Feb 2.
3
Effect of fluoxetine on disease progression in a mouse model of ALS.
氟西汀对 ALS 小鼠模型疾病进展的影响。
J Neurophysiol. 2014 Jun 1;111(11):2164-76. doi: 10.1152/jn.00425.2013. Epub 2014 Mar 5.
4
Amyotrophic lateral sclerosis: thyroid and prolactin hormone changes in thyrotropin-releasing hormone therapy.肌萎缩侧索硬化症:促甲状腺激素释放激素治疗中甲状腺和催乳素激素的变化
Ital J Neurol Sci. 1990 Dec;11(6):601-3. doi: 10.1007/BF02337445.
5
Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.在慢性促甲状腺激素释放激素输注治疗肌萎缩侧索硬化症期间,催乳素对生长激素释放激素的反应。
J Endocrinol Invest. 1990 Sep;13(8):631-6. doi: 10.1007/BF03349584.